Amcor: Cheap Multiple Masks Elevated Leverage and Integration Risks

What happened

Amcor trades at a 10x forward P/E with a 6.5% dividend yield, prompting some analysts to label it a value buy. However, our DeepValue analysis reveals net debt/EBITDA of 8x, interest coverage of only 2.5x, and GAAP operating margins compressed to 6.7% from ~10% in 2023. The stock also sits ~58% above a conservative DCF estimate of $5.28 per share, implying investors are already pricing in successful Berry synergy delivery. Integration risks, regulatory headwinds on plastics and PFAS, and a strategic review of $2.5bn in sales add further uncertainty. While the dividend is sustainable for now, the balance sheet leaves little margin for error, making the apparent value a potential trap.

Implication

For investors, the Seeking Alpha bullish thesis rests on a 10x forward P/E and a 6.5% yield, but the DeepValue report highlights that the company carries net debt/EBITDA of 8x and interest coverage of just 2.5x, leaving little room for error. The stock has fallen ~18% over 12 months yet still trades above intrinsic value under conservative assumptions. Any shortfall in synergy delivery, further margin compression, or adverse regulatory outcomes could pressure the dividend or force equity dilution. The strategic review of ~$2.5bn in sales adds portfolio uncertainty. Until clear evidence of deleveraging and margin repair emerges, the skewed risk/reward favors staying on the sidelines.

Thesis delta

The Seeking Alpha article positions Amcor as a value play at a low P/E with a high dividend, while the DeepValue report warns that the apparent bargain is offset by dangerous leverage, margin erosion, and integration/regulatory risks. The delta is that the valuation multiple may be justified by the balance sheet and execution challenges, making the stock a potential value trap rather than a true opportunity. The bullish case fails to adequately discount the financial risk and the possibility that synergies may not materialize as planned.